The nature of the principal type 1 interferon-producing cells in human blood, Science, vol.284, pp.1835-1842, 1999. ,
IPC: professional type 1 interferon-producing cells 2. and plasmacytoid dendritic cell precursors, Annu Rev Immunol, vol.23, pp.275-306, 2005. ,
Plasmacy-3. toid dendritic cells activated by infl uenza virus and CD40L drive a potent TH1 polarization, Nat Immunol, vol.1, pp.305-315, 2000. ,
,
Human immunodefi ciency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells, J Virol, vol.78, pp.5223-5255, 2004. ,
,
Activation of infl uenza virus-specifi c CD4 ? and CD8 ? T cells: a new role for plasmacytoid dendritic cells in adaptive immunity, Blood, vol.101, pp.3520-3526, 2003. ,
Antigen crosspresentation by human plasmacytoid dendritic cells, Immunity, vol.27, pp.481-92, 2007. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00360697
Advances in cell separation: recent developments in 7. counterfl ow centrifugal elutriation and continuous fl ow cell separation, J Chromatogr B Biomed Sci Appl, vol.722, pp.55-69, 1999. ,
Isolation of 8. human monocyte populations, Curr Protoc Immunol, vol.7, p.6, 2006. ,
,
Vrielink H, Marieke van Ham S. Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation, Immunobiology, vol.14, pp.633-673, 2006. ,
,
Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation, J Exp Med, vol.203, pp.1999-2008, 2006. ,
,
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood, J Immunol, vol.165, pp.6037-6083, 2000. ,
Wei-17. mar W, van Besouw NM. Peripheral blood manipulation signifi cantly affects the result of dendritic cell monitoring, Transpl Immunol, vol.17, pp.169-77, 2007. ,
, within a closed system (Elutra) for clinical-scale generation of dendritic cells, J Immunol Methods, vol.298, pp.61-72, 2005.
,
Effi cient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modifi ed counterfl ow centrifugal elutriation program, Cytotherapy, vol.11, pp.923-958, 2009. ,
Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivity, Cytotherapy, vol.11, pp.218-246, 2009. ,
Zeill-12. inger R. Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept, Cytometry B Clin Cytom, vol.80, pp.100-111, 2011. ,
Blood monocytes: 13. development, heterogeneity, and relationship with dendritic cells, Annu Rev Immunol, vol.27, pp.669-92, 2009. ,